💚 Health & Wellness

June 10th, 2026

Today's top 5 stories, curated by Daily Direct.

Stat News

STAT+: Your sepsis algorithm shouldn’t require a time machine

Sepsis prediction algorithms are only as good as the data feeding them, and messy, inconsistent medical records are quietly undermining their reliability. This edition of AI Prognosis examines the practical data quality problems that cause even well-designed models to stumble in real clinical environments. Also covered: AI scribes built for patients rather than providers, and the latest AI-driven developments in biotech.

Read article →
Medical Xpress

CRISPR enzyme precisely detects and shreds DNA in cancer mutations once considered 'undruggable'

A team led by Nobel laureate Jennifer Doudna has identified a new use for the CRISPR enzyme Cas12a2: selectively detecting and destroying cancer cells harboring mutations previously considered impossible to target with drugs. Unlike traditional gene editing, the approach exploits Cas12a2's ability to trigger broad cellular destruction upon recognizing a specific genetic sequence, effectively turning the mutation into a death signal. The findings, published in Nature, could open a new front in precision oncology for some of the most treatment-resistant cancers.

Read article →
Medical Xpress

Uncertainty-aware AI and lensfree holography enable reliable automated HER2 assessment for breast cancer diagnostics

Researchers have combined uncertainty-aware AI with lensfree holographic imaging to automate HER2 scoring in breast cancer tissue — a critical step in determining treatment eligibility. The approach sidesteps the need for expensive conventional microscopy while giving clinicians a built-in confidence metric for each AI prediction. If validated at scale, the method could significantly lower the cost and complexity of deploying AI diagnostics in under-resourced settings.

Read article →
KFF Health News

FDA’s Greenlight of Old Chemical Offers Chance To Restore Faith in Sunscreen

The FDA has approved bemotrizinol, a UV-filtering sunscreen chemical that has been used safely in Europe, Asia, and Australia for over two decades. The long-awaited approval marks a significant regulatory breakthrough, as the U.S. had fallen notably behind other countries in modernizing its sunscreen ingredient approvals. Industry groups and health advocates see the move as an opportunity to rebuild consumer confidence in sunscreen products at a time when misinformation about their safety has eroded public trust.

Read article →
Stat News

OB-GYN association, deviating from CDC guidance, issues its own vaccine recommendations

The American College of Obstetricians and Gynecologists has broken from the CDC to release its own recommended vaccine schedule for pregnant patients. The move signals a notable fracture between major medical bodies on prenatal care guidelines. For OB-GYNs and their patients, the divergence raises practical questions about which recommendations to follow in the exam room.

Read article →

Get this delivered every morning

Join thousands of readers who get the world's most important stories, curated daily.

Start reading free →